Endogenous and Exogenous Hydrogen Sulfide Promotes Resolution of Colitis in Rats

Gastroenterology

Volumn 137, Issue 2, 2009, Pages

  Wallace, John L ^a   Vong, Linda ^a   McKnight, Webb ^a   Dicay, Michael ^a   Martin, Gary R ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; CYSTATHIONINE GAMMA LYASE; CYSTATIONINE BETA SYNTHASE; HYDROGEN SULFIDE; LAWESSON REAGENT; MESSENGER RNA; POTASSIUM CHANNEL; PROSTAGLANDIN; SODIUM HYDROGEN SULFIDE; SYNTHETASE; TRINITROBENZENESULFONIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; INTESTINE MUCOSA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 67651001726     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.04.012     Document Type: Article

References (48)

1. 2S be the third endogenous gaseous transmitter?. FASEB J 16 (2002) 1792-1798
2. Abe K., and Kimura H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci 16 (1996) 1066-1071
3. Zanardo R.C., Brancaleone V., Distrutti E., et al. Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J 20 (2006) 2118-2120
4. Fiorucci S., Distrutti E., Cirino G., et al. The emerging roles of hydrogen sulfide in the gastrointestinal tract and liver. Gastroenterology 131 (2006) 259-271
5. ATP channels. J Pharmacol Exp Ther 316 (2006) 325-335
6. Fiorucci S., Antonelli E., Distrutti E., et al. Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs. Gastroenterology 129 (2005) 1210-1224
7. Wallace J.L., Dicay M., McKnight W., et al. Hydrogen sulfide enhances ulcer healing in rats. FASEB J 21 (2007) 4070-4076
8. Schicho R., Krueger D., Zeller F., et al. Hydrogen sulfide is a novel prosecretory neuromodulator in the guinea-pig and human colon. Gastroenterology 131 (2006) 1542-1552
9. Magee E.A., Richardson C.J., Hughes R., et al. Contribution of dietary protein to sulfide production in the large intestine: an in vitro and a controlled feeding study in humans. Am J Clin Nutr 72 (2000) 1488-1494
10. Macfarlane G.T., Gibson G.R., and Cummings J.H. Comparison of fermentation reactions in different regions of the human colon. J Appl Bacteriol 72 (1992) 57-64
11. Levitt M.D., Springfield J., Furne J., et al. Physiology of sulfide in the rat colon: use of bismuth to assess colonic sulfide production. J Appl Physiol 92 (2002) 1655-1660
12. Roediger W.E. The colonic epithelium in ulcerative colitis: an energy-deficiency disease?. Lancet 2 (1980) 712-715
13. Roediger W.E., Duncan A., Kapaniris O., et al. Sulphide impairment of substrate oxidation in rat colonocytes: a biochemical basis for ulcerative colitis?. Clin Sci (Lond) 85 (1993) 623-627
14. Attene-Ramos M.S., Wagner E.D., Plewa M.J., et al. Evidence that hydrogen sulfide is a genotoxic agent. Mol Cancer Res 4 (2006) 9-14
15. Babidge W., Millard S., and Roediger W. Sulfides impair short chain fatty acid β-oxidation at acyl-CoA dehydrogenase level in colonocytes: implications for ulcerative colitis. Mol Cell Biochem 181 (1998) 117-124
16. Jorgensen J., and Mortensen P.B. Hydrogen sulfide and colonic epithelial metabolism: implications for ulcerative colitis. Dig Dis Sci 46 (2001) 1722-1732
17. Picton R., Eggo M.C., Langman M.J., et al. Impaired detoxification of hydrogen sulfide in ulcerative colitis?. Dig Dis Sci 52 (2007) 373-378
18. Moore J., Babidge W., Millard S., et al. Colonic luminal hydrogen sulfide is not elevated in ulcerative colitis. Dig Dis Sci 43 (1998) 162-165
19. Goubern M., Andriamihaja M., Nübel T., et al. Sulfide, the first inorganic substrate for human cells. FASEB J 21 (2007) 1699-1706
20. Fiorucci S., Orlandi S., Mencarelli A., et al. Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis. Br J Pharmacol 150 (2007) 996-1002
21. Oh G.-S., Pae H.O., Lee B.S., et al. Hydrogen sulfide inhibits nitric oxide production and nuclear factor-κB via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide. Free Rad Biol Med 41 (2006) 106-119
22. Li L., Rossoni G., Sparatore A., et al. Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative. Free Radic Biol Med 42 (2007) 706-719
23. Morris G.P., Beck P.L., Herridge M.S., et al. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96 (1989) 795-803
24. Wallace J.L., MacNaughton W.K., Morris G.P., et al. Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. Gastroenterology 96 (1989) 29-36
25. 2. Am J Pathol 167 (2005) 1293-1300
26. Qu K., Chen C.P., Halliwell B., et al. Hydrogen sulfide is a mediator of cerebral ischemic damage. Stroke 37 (2006) 889-893
27. Abeles R.H., and Walsh C.T. Acetylenic enzyme inactivators. Inactivation of γ-cystathionase, in vitro and in vivo, by propargylglycine. J Am Chem Soc 95 (1973) 6124-6125
28. Pfeffer M., and Ressler C. Beta-cyanoalanine, an inhibitor of rat liver cystathionase. Biochem Pharmacol 16 (1967) 2299-2308
29. Bradley P.P., Priebat D.A., Christensen R.D., et al. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78 (1982) 206-209
30. Boughton-Smith N.K., Wallace J.L., and Whittle B.J. Relationship between arachidonic acid metabolism, myeloperoxidase activity and leukocyte infiltration in a rat model of inflammatory bowel disease. Agents Actions 25 (1988) 115-123
31. ATP channel opener. EMBO J 20 (2001) 6008-6016
32. Wallace J.L., Caliendo G., Santagada V., et al. Gastrointestinal safety and anti-inflammatory effects of a hydrogen sulfide-releasing diclofenac derivative in the rat. Gastroenterology 132 (2007) 261-271
33. Foster D.C., and Hasday J.D. Elevated tissue levels of interleukin-1β and tumor necrosis factor-α in vulvar vestibulities. Obstet Gynecol 89 (1997) 291-296
34. Chávez-Piña A.E., Vong L., McKnight W., et al. Lack of effects of acemetacin on signalling pathways for leukocyte adherence may explain its gastrointestinal safety. Br J Pharmacol 155 (2008) 857-864
35. Szabo C. Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 6 (2007) 917-935
36. Whiteman M., Armstrong J.S., Chu S.H., et al. The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite "scavenger"?. J Neurochem 90 (2004) 765-768
37. Benavides G.A., Squadrito G.L., Mills R.W., et al. Hydrogen sulfide mediates the vasoactivity of garlic. Proc Natl Acad Sci U S A 104 (2007) 17977-17982
38. Bai A.P., Ouyang Q., and Hu R.W. Diallyl trisulfide inhibits tumour necrosis factor-α expression in inflamed mucosa of ulcerative colitis. Dig Dis Sci 50 (2005) 1426-1431
39. Gilroy D.W., Colville-Nash P.R., Willis D., et al. Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med 5 (1999) 698-701
40. Serhan C.N., Brain S.D., Buckley C., et al. Resolution of inflammation: state of the art, definitions and terms. FASEB J 21 (2007) 325-332
41. Wallace J.L., Bak A., McKnight W., et al. Cyclooxygenase-1 contributes to inflammatory responses in rats and mice: implications for GI toxicity. Gastroenterology 115 (1998) 101-109
42. Reuter B.K., Asfaha S., Buret A., et al. Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. J Clin Invest 98 (1996) 2076-2085
43. 2 is an early anti-inflammatory signal in experimental colitis. Am J Physiol 279 (2000) G238-G344
44. Pitcher M.C., Beatty E.R., and Cummings J.H. The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis. Gut 46 (2000) 64-72
45. Levine J., Ellis C.J., Furne J.K., et al. Fecal hydrogen sulfide production in ulcerative colitis. Am J Gastroenterol 93 (1998) 83-87
46. Suarez F., Furne J., Springfield J., et al. Production and elimination of sulfur-containing gases in the rat colon. Am J Physiol 274 (1998) G727-G733
47. Furne J.K., Suarez F.K., Ewing S.L., et al. Binding of hydrogen sulphide by bismuth does not prevent dextran sulphate-induced colitis in rats. Dig Dis Sci 45 (2000) 1439-1443
48. Xu X.M., Yu J.P., He X.F., et al. Effects of garlicin on apoptosis in rat model of colitis. World J Gastroenterol 11 (2005) 4579-4582